How many analysts have analysed VACCINEX INC (VCNX)?
The number of analysts covering VACCINEX INC (VCNX) is 7.
VACCINEX INC (VCNX) Forecast, Price Target & Analyst Ratings
NASDAQ:VCNX • US9186403013
Current stock price
1.41 USD
-2.24 (-61.37%)
At close:
1.3211 USD
-0.09 (-6.3%)
After Hours:
Analyst forecast overview
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for VACCINEX INC (VCNX).
Forecast Snapshot
Price Target Details & History
Consensus Price Target and Range
Mean target
N/A
Upside
N/A
From current price of $1.41 to mean target of N/A, Based on 7 analyst forecasts
Low
N/A
Median
N/A
High
N/A
Price Target Revisions
1 Month
N/A
3 Months
N/A
Price Target Summary
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
85.71%
VCNX was analyzed by 7 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about VCNX.
In the previous month the buy percentage consensus was at a similar level.
VCNX was analyzed by 7 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
- Release Date
- N/A
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 900K 44.00% | 275K -69.44% | 570K 107.27% | |
| EBITDA YoY % growth | -22.321M 20.35% | -19.699M 11.75% | -22.766M -15.57% | |
| EBIT YoY % growth | -22.49M 20.62% | -19.906M 11.49% | -22.885M -14.97% | |
| Operating Margin | -2,498.89% | -7,238.55% | -4,014.91% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in USD
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A